Create Free Account

By creating account you will get access to hot stocks & personalised emails

Inhalerx Ltd

Healthcare AU IRX

0.02AUD
-(-%)

Last update at 2025-01-28T23:00:00Z

Day Range

0.020.02
LowHigh

52 Week Range

0.020.05
LowHigh

Fundamentals

  • Previous Close 0.02
  • Market Cap5.34M
  • Volume0
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.41374M
  • Revenue TTM0.89M
  • Revenue Per Share TTM0.005
  • Gross Profit TTM 0.89M
  • Diluted EPS TTM-

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -1.89661M -1.11113M -1.01134M -2.27266M -1.74922M
Minority interest - - - - 0.05M
Net income -1.89661M -1.11113M -1.01134M -2.27266M -1.67572M
Selling general administrative 0.51M 0.56M 0.31M 0.79M 1.42M
Selling and marketing expenses 0.03M 0.05M 0.04M 0.05M -
Gross profit 0.02M 0.05M -0.02643M 0.05M 0.35M
Reconciled depreciation 0.00052M 0.00181M - 0.06M 0.08M
Ebit -1.92366M -1.12590M -1.20557M -1.64049M -1.92785M
Ebitda -1.92314M -1.12409M -1.02120M -1.57933M -1.87788M
Depreciation and amortization 0.00052M 0.00181M - 0.06M -
Non operating income net other - - - - -
Operating income -1.92366M -1.12590M -1.02120M -1.64049M -1.95937M
Other operating expenses 1.95M 1.29M 1.12M 2.15M 0.28M
Interest expense - 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision 0.00000M 0.00000M 0.00000M 0.00000M -0.02660M
Interest income 0.02M 0.00033M 0.00029M 0.02M 0.05M
Net interest income 0.02M 0.00033M 0.00029M 0.02M 0.05M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.01613M -0.00033M - 0.44M -0.02660M
Total revenue 0.02M 0.17M 0.10M 0.05M 0.35M
Total operating expenses 1.95M 1.18M 0.99M 2.15M -
Cost of revenue 0.00000M 0.12M 0.12M 0.17M 0.20M
Total other income expense net 0.01M 0.01M 0.00957M -0.18872M 0.16M
Discontinued operations - - - - -
Net income from continuing ops -1.89661M -1.11113M -1.20528M -2.38774M -1.72263M
Net income applicable to common shares -1.92705M -1.11113M -1.20528M -2.38774M -1.67572M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 1.58M 2.26M 2.93M 1.90M 0.62M
Intangible assets - 0.01M 0.01M 0.00430M 0.00000M
Earning assets - - - - -
Other current assets 0.06M -0.00000M 0.00108M 0.00240M 0.09M
Total liab 0.91M 0.36M 0.25M 0.58M 0.28M
Total stockholder equity 1.00M 1.90M 2.68M 1.32M 0.34M
Deferred long term liab - - - - -
Other current liab 0.17M 0.26M 0.18M 0.46M 0.22M
Common stock 14.08M 13.93M 12.90M 10.56M 8.24M
Capital stock - 13.93M 12.90M 10.45M 8.24M
Retained earnings -13.16916M -11.69545M -9.25430M -7.94924M -7.04282M
Other liab - - - - -
Good will - - - - -
Other assets - - - - 0.07M
Cash 0.72M 2.13M 2.80M 1.72M 0.42M
Cash and equivalents - 2.13M 2.80M 1.72M 0.42M
Total current liabilities 0.91M 0.36M 0.25M 0.58M 0.28M
Current deferred revenue - - - - -
Net debt -0.15554M -2.13339M -2.80348M -1.71948M -0.42496M
Short term debt 0.56M 0.00000M 0.00000M 0.00000M 0.00000M
Short long term debt - - - - -
Short long term debt total 0.56M - - - -
Other stockholder equity - -0.02523M -0.96899M -0.29476M -0.10145M
Property plant equipment - 0.00000M 0.00971M - 0.00000M
Total current assets 1.58M 2.24M 2.91M 1.90M 0.55M
Long term investments - - - - -
Net tangible assets - 1.91M 2.66M 1.32M 0.34M
Short term investments - - - - -
Net receivables 0.80M 0.03M 0.02M 0.12M 0.17M
Long term debt - - - - -
Inventory - 0.08M 0.02M 0.04M -0.12881M
Accounts payable 0.18M 0.10M 0.07M 0.12M 0.07M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.09M -0.30408M -0.96899M -0.98781M -0.75883M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - 0.01M 0.02M 0.00430M 0.07M
Capital lease obligations - - - - -
Long term debt total - 0.00000M 0.00000M 0.00000M 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.00017M -0.02509M -0.00430M -0.03634M -0.13704M
Change to liabilities 0.08M -0.11604M 0.10M -0.12470M -0.36129M
Total cashflows from investing activities -0.00018M -0.02509M -0.00430M -0.03634M -0.13704M
Net borrowings - - - - -
Total cash from financing activities 1.18M 2.26M 2.37M 2.37M 2.37M
Change to operating activities -0.01439M 0.04M -0.07066M -0.01181M -0.01030M
Net income -1.89661M -1.11113M -1.20528M -2.38774M -1.67572M
Change in cash -0.67009M 1.08M 1.29M -1.88955M -2.20150M
Begin period cash flow 2.80M 1.72M 0.42M 2.31M 4.52M
End period cash flow 2.13M 2.80M 1.72M 0.42M 2.31M
Total cash from operating activities -1.84630M -1.14857M -1.04924M -1.86618M -2.06447M
Issuance of capital stock 1.20M 2.27M 2.41M - -
Depreciation 0.00052M 0.00181M 0.00181M 0.06M 0.03M
Other cashflows from investing activities - - - 0.00000M -0.03788M
Dividends paid - - - - -
Change to inventory - -0.02060M -0.02060M -0.02060M -
Change to account receivables - 0.06M 0.09M 0.06M 0.08M
Sale purchase of stock -0.02362M -0.01377M 2.41M - -
Other cashflows from financing activities -0.00017M -0.02509M -0.03653M -0.03634M -0.03653M
Change to netincome 0.05M 0.00430M 0.03M 0.54M -0.16537M
Capital expenditures 0.00017M 0.03M 0.00430M 0.04M 0.09M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.02M 0.00033M 0.01M 0.11M 0.06M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow -0.00017M -0.02509M -0.00430M -0.03634M -2.16363M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
IRX
Inhalerx Ltd		 - -% 0.02 - - 6.01 9.12 273.62 -3.5284
COH
Cochlear Ltd		 2.90 0.92% 318.82 57.66 49.26 9.13 11.19 9.09 35.12
PNV
Polynovo Ltd		 -0.055 2.50% 2.15 228.50 151.52 15.29 21.93 15.03 383.36
EBR
Ebr Systems Inc CDR		 -0.05 2.86% 1.70 - - - 12.46 - -3.6785
AVH
Avita Therapeutics Inc		 -0.04 1.31% 3.02 - - 6.00 18.59 3.83 -10.0538

Reports Covered

Stock Research & News

View All

Profile

InhaleRx Limited engages in the developing and commercializing of medical drug delivery systems in Australia. It also develops inhaled drug formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Melbourne, Australia.

Inhalerx Ltd

414 Latrobe Street, Melbourne, VIC, Australia, 3000

Key Executives

Name Title Year Born
Mr. Darryl Davies Chief Exec. Officer NA
Dr. Robert Jenny Ph.D. Chief Scientific Officer NA
Mr. Srinivasa Rao Suryadevara Exec. VP 1968
Ms. Nova Anne Taylor Company Sec. NA
Ms. Elizabeth Spooner Joint Company Sec. NA
Mr. Darryl Davies B.Sc. Chief Executive Officer NA
Dr. Robert Jenny B.A., B.Sc., Ph.D. Chief Scientific Officer NA
Mr. Srinivasa Rao Suryadevara Executive Vice President 1968
Mr. James Stephen Barrie CPA Company Secretary NA
Mr. Darryl Davies B.Sc. Chief Executive Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

Market Research
ISO Certified pcidss

Kalkine Solutions Private Limited, an authorized representative of Kalkine Pty Ltd, holds the ISO 27001:2022 certification (Certificate No. IC-IS-2404072) and the PCI-DSS Version 4.0 Level 1 certification (Certificate No. CSNL1PCI8067).

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2025 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.